For patients comfortable with manual injection, compounded options offer comparable efficacy at lower cost (Fitch et al., Obesity, 2024)
Mississippi banned off-label prescribing of GLP-1s for weight loss (you must use FDA-approved obesity versions like Wegovy, not Ozempic)
New medications are on the horizon, like those combining GLP-1 with other hormones (like amylin), oral versions that could compete with injectable semaglutide, and even triple-action drugs
Dosing a short-acting GHRH analog (sermorelin, no-DAC CJC) at bedtime stacks the peptides pulse on top of the natural one, amplifying it rather than fighting it
At lower doses, receptor activation may still occur, but the strength and consistency of appetite suppression have not been defined in controlled trials
Since type AB is universal plasma, meaning it can be transfused to any patient, we are always looking for more plasma donors with AB- or AB+ blood type